Perspective Therapeutics, Inc.
AMEX: CATX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Johan Spoor
- Employees
- 138
- Headquarters
- Seattle, United States
- IPO year
- 2005
- Market cap
- $227.9M
- Website
- https://www.perspectivetherapeutics.com
Loading CATX…
Loading profile data…Frequently asked questions about CATX
What does Perspective Therapeutics, Inc. (CATX) do?
Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within t...
Where does CATX trade?
Perspective Therapeutics, Inc. (CATX) trades on the New York Stock Exchange American.
What sector is CATX in?
Perspective Therapeutics, Inc. (CATX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Perspective Therapeutics, Inc.?
Johan Spoor is the chief executive officer of Perspective Therapeutics, Inc. (CATX).
Where is Perspective Therapeutics, Inc. headquartered?
Perspective Therapeutics, Inc. is headquartered in United States.
Does CATX pay a dividend?
Perspective Therapeutics, Inc. (CATX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CATX go public?
Perspective Therapeutics, Inc. (CATX) completed its initial public offering in 2005.